Atopic Dermatitis Linked to Shorter Stature in Early Childhood
Associations of atopic dermatitis with height and BMI decreased by age 14 and 5.5 years, respectively
Atopic Dermatitis
Atopic Dermatitis Management
Recommendations for the non-pharmacologic and pharmacologic management of atopic dermatitis.
FDA Grants Fast Track Designation to Orismilast for Atopic Dermatitis
The FDA’s Fast Track process allows for expedited review of drugs that are expected to fill an unmet need.
MPR Weekly Dose Podcast Episode 94
The Pfizer-BioNTech COVID-19 vaccine gets Emergency Use Authorization for booster doses in certain individuals; A smaller vaccine dose appears safe and effective in children; A survey sheds light on parents’ thoughts on child COVID vaccination; Janssen share booster data for their vaccine; Remdesivir efficacy data in COVID-19 patients, And Opzelura is approved for atopic dermatitis.
Opzelura Cream Approved for Atopic Dermatitis
The Food and Drug Administration has approved Opzelura (ruxolitinib) cream for the short-term and noncontinuous chronic treatment of mild to moderate atopic dermatitis in nonimmunocompromised patients 12 years of age and older whose disease is not adequately controlled with topical prescription therapies, or when those therapies are not advisable. The approval was based on data…
Atopic Dermatitis Improvements Seen in Very Young Treated With Dupilumab
The phase 3 trial evaluated dupilumab, in addition to standard of care low potency topical corticosteroids, in 162 patients aged 6 months to 5 years with uncontrolled moderate to severe atopic dermatitis.
Factors Linked to Development of Pediatric Psoriasis Identified
Factors independently linked to development include atopic dermatitis, family history of psoriasis, skin and fungal infections
Skin Clearance, Itch Improvement Seen With Lebrikizumab in Atopic Dermatitis Trials
Lebrikizumab is a novel humanized monoclonal antibody that selectively inhibits IL-13.
FDA Approves Dupixent 200mg Single-Dose Prefilled Pen
The new 200mg single-dose prefilled pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration.
Baricitinib Shows Long-Term Efficacy for Atopic Dermatitis
Long-term sustained outcomes seen among adults with moderate-to-severe atopic dermatitis
